The rapid evolution of cell and gene therapy (CGT) has driven demand for advanced sterile connector technology that ensures media transfer while maintaining process integrity, scalability, and regulatory compliance. CPC innovations in single-use sterile connectors are transforming CGT process manufacturing by enhancing fluid handling efficiency, reducing contamination risks, and enabling seamless integration into closed system manufacturing.